Centessa Pharmaceuticals plc

NASDAQ:CNTA

13.72 (USD) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -235.757-151.085-216.207-381.854-10.663-5.061
Depreciation & Amortization 0.9420.810.1310.03400.006
Deferred Income Tax 2.653-26.632-2.857-6.80400.001
Stock Based Compensation 33.54629.39224.96514.8520.3360.236
Change In Working Capital 22.102-18.858-2.831-5.378-0.489-1.006
Accounts Receivables 00-11.704-6.72100
Inventory 0011.704-4.15700
Accounts Payables -4.585-2.7336.3514.157-0.0490.855
Other Working Capital 26.687-16.125-9.1821.343-0.44-1.861
Other Non Cash Items 34.4596.031-3.747257.8460.186-0.001
Operating Cash Flow -142.055-160.342-200.546-136.142-10.63-5.825
Investing Activities:
Investments In Property Plant And Equipment -0.034-0.169-1.137-0.18600
Acquisitions Net 00063.43400
Purchases Of Investments 31.301-264.910000
Sales Maturities Of Investments 0138.0750000
Other Investing Activites 000.206-000
Investing Cash Flow 31.267-127.004-0.93163.24800
Financing Activities:
Debt Repayment -0.7620073.931.3613.831
Common Stock Issued 359.60520.8070.718586.4420.010
Common Stock Repurchased 000-0.01200
Dividends Paid 000000
Other Financing Activities 5.9090.310.457586.1380.0015.174
Financing Cash Flow 364.75221.1170.457660.0681.3629.005
Other Information:
Effect Of Forex Changes On Cash 1.2270.615-0.4181.902-0.0750.52
Net Change In Cash 255.191-265.614-201.438590.079-9.3433.7
Cash At End Of Period 383.221128.03393.644595.0827.22716.57